EP Patent

EP1313511A2 — Testosterone ester formulation for human use

Assigned to Organon NV · Expires 2003-05-28 · 23y expired

What this patent protects

Disclosed is a formulation of testosterone decanoate for use in the treatment of humans. In contrast with known formulations comprising testosterone decanoate, it was found that any other esters of testosterone normally present together with testosterone decanoate, can be omitted…

USPTO Abstract

Disclosed is a formulation of testosterone decanoate for use in the treatment of humans. In contrast with known formulations comprising testosterone decanoate, it was found that any other esters of testosterone normally present together with testosterone decanoate, can be omitted and the formulation thus comprises testosterone decanoate as the sole ester of testosterone.

Drugs covered by this patent

Patent Metadata

Patent number
EP1313511A2
Jurisdiction
EP
Classification
—
Expires
2003-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Organon NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.